TUESDAY, Jan. 21, 2025 (HealthDay News) — Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia.  But these drugs also come with risks that shouldn’t be overlooked, researchers warn in a study publishedContinue Reading

The way obesity is diagnosed needs to become more sophisticated, an international commission has concluded. Using body-mass index (BMI) to tell who is overweight or obese is not reliable, and can result in misdiagnosis, the Commission on Clinical Obesity says in a new paper published today in The Lancet DiabetesContinue Reading

THURSDAY, Dec. 19, 2024 (HealthDay News) — The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA firstContinue Reading

THURSDAY, Dec. 12, 2024 (HealthDay News) — Unhealthy ultra-processed foods have wormed their way into American kitchens, likely harming people’s health for decades, a new study warns. More than half of the calories adults eat at home now come from ultra-processed foods, which contain high levels of sugar, salt, fatContinue Reading